COVID-19 has brought to light many failures in our healthcare system – including the long-running issue of the lack of diversity in clinical trials. To understand how therapeutics or vaccines may affect a large population of patients, clinical trials should include a representation of the people…

On March 16, 2021, a lone white gunman went on a shooting spree in three spas in the Atlanta area and killed eight people—six of whom were Asian women. This vicious crime is another indicator of rising anti-Asian sentiment in the United States. Research released by the organization Stop AAPI Hate…

Mapillar Dahn has three daughters—and they all have sickle cell disease. But she gained hope thanks to Global Blood Therapeutics (GBT) drug Oxbryta, the first FDA-approved drug targeting the underlying cause of sickle cell disease rather than just its symptoms. Dahn’s oldest daughter, Tully, was…

Less than a month ago, the United States inaugurated the first-ever Black woman and South Asian woman to the vice presidency, Kamala Harris. This historic moment of progress occurred against the backdrop of a shameful attempted insurrection at the U.S. Capitol, which included the active…

Day #2 of the BIO CEO & Investor Conference was all about the future. How can we ensure the workforce reflects the diverse demographics of the patients the industry serves? What does the future of biotech investment look like? How can we incentivize innovation? Here are some takeaways from …

Last month, the Biotechnology Innovation Organization (BIO) released the first annual report measuring diversity and inclusion in the biotech industry, with real, practical solutions for making the biotech workforce more representative of the industry’s customers and patients. During the BIO CEO …

For the first time ever, BIO took a comprehensive look at the state of diversity and inclusion in the biotech industry. The findings are in a newly released report, “Measuring Diversity in the Biotech Industry: Building an Inclusive Workforce.”  Image …

As more biotechnology executives begin to focus on strategies to diversify their boards to avoid groupthink and strengthen corporate governance, an emerging consensus is forming that initial public offerings are a key gateway to assembling higher-performing leadership teams. That was the unanimous…